publication venue for Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study.. 9:733-746. 2021 Inhaled corticosteroids in children: effects on bone mineral density and growth.. 2:487-496. 2014
